Glycemic control in patients with diabetes in Finland

Citation
T. Valle et al., Glycemic control in patients with diabetes in Finland, DIABET CARE, 22(4), 1999, pp. 575-579
Citations number
25
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETES CARE
ISSN journal
01495992 → ACNP
Volume
22
Issue
4
Year of publication
1999
Pages
575 - 579
Database
ISI
SICI code
0149-5992(199904)22:4<575:GCIPWD>2.0.ZU;2-D
Abstract
OBJECTIVE - To evaluate the quality of diabetes care at a national level in Finland, using level of glycemia as a determinant of success in treatment. RESEARCH DESIGN AND METHODS - Physicians and diabetes nurses in 76 randomly selected clinics (59 primary care units and 17 hospitals) evenly covering the whole of Finland were asked to fill in a questionnaire asking for data based on the 1993 medical records of a random sample of 50 diabetic patient s from each center (total n = 3,800). HbA(1c) was used as an index of glyce mic control. RESULTS - Information on 3,195 (84%) diabetic patients was received. HbA(1c ) was measured in 67% of the patients in 1993. The mean HbA(1c) in the whol e population was 8.6 +/- 1.9% (normal range 4-6%). Some 25% of patients had HbA(1c) less than or equal to 7.3%, while 25% had HbA(1c) greater than or equal to 9.7%. The mean HbA(1c) was 8.8 +/- 1.9% in type 1 and 8.5 +/- 1.9% in type 2 diabetic patients. There was no sell difference in the HbA(1c) l evel in type 1 diabetic patients. However, male type 2 diabetic patients ha d better glycemic control than female patients (8.3 +/- 1.9 vs. 8.8 +/- 1.9 %, P < 0.0001). The sex difference was independent of the type of therapy. The mean level of glycemic control was lowest among individuals with the sh ortest duration of diabetes. After 7-9 years after the diagnosis, there was no change in the mean level of glycemia. CONCLUSIONS - Average glycemic control is poor in a majority of the diabeti c patients in Finland, Better treatment strategies and methods should be us ed to improve glycemic control and to reduce long-term complications.